Trial Design - Applied Clinical Trials


Trial Design Zone
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more.


Ethnobridging to Accelerate Global Drug Development
October 16, 2013
Multinational pharmaceutical companies are under intense financial and competitive pressures to make the drug development process more effective and efficient, and to expand into a greater number of international markets.
A PK Mystery Solved
October 1, 2014
How modeling and simulation clarified complex exposure levels and an orphan drug got approved.
Demonstrating Biosimilarity: PK Considerations
October 1, 2014
Proving a biosimilar's pharmacokinetic 'equivalence' requires adherence to several unique factors.
Blood Pressure Evaluation During Early Phase Trials
October 1, 2014
A systematic approach for early identification of BP effects during development of new drugs.
Is 'Open Integration' Beyond Our Reach?
October 1, 2014
Research shows that the potential of integrated alliances remains elusive in the near term.
Patient-Centric Trial Design
Feb 3, 2015 - Feb 4, 2015
Philadelphia, PA USA

Articles By Category
Adaptive design, Phase 1–2, trial modification
Click Here for Articles

Phase IV, postapproval, monitoring, safety
Click Here for Articles

Pediatrics, oncology, diabetes, and other therapeutic areas
Click Here for Articles

Aptuit Offers Fast, Preliminary Hippocampal Screening Studies for CNS Drugs
ERT, Johns Hopkins University and the University of Washington Expand Study on Effects of Home-Health Monitoring on Exacerbations of Cystic Fibrosis
Coalition for Accelerating Standards and Therapies (CFAST) Announces a Resource for Parkinson's Disease Clinical Development
Verastem Enters Biomarker Agreement with LabCorp for Cancer Stem Cell Agent Companion Diagnostic
Analysis Proves Positive for RBM
Untitled Document
Click here